LRP6 and colorectal carcinoma: If LRP6 overexpression is associated with the malignant phenotype of CRC independent of the Wnt/β-catenin pathway, it is possible that the combined inhibition of LRP6 with an intracellular component or transcription cofactors of the Wnt/β-catenin pathway may have additive or synergistic effects.